Toshimi Takano

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Toshimi Takano
Jan 29, 2025, 22:27 | Blog
Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2− breast cancer
Kristina Jankovic, Medical Oncology Resident at University Clinical Center Nis, shared on X: "Phase 3…
Jan 29, 2025, 08:05 | Blog
Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced/Metastatic Breast Cancer
Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, shared a post on X: "Final…
Jan 28, 2025, 15:01 | Insight
Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Check out the Breast Cancer Research Digest…
Jan 13, 2025, 10:23 | Science
The Randomized Noninferiority Phase III EMERALD Trial on HER2+ Locally Advanced/Metastatic Breast Cancer
A recent paper by Toshinari Yamashita et al. was published in the Journal of Clinical…
Jan 12, 2025, 08:51 | Blog
Eribulin + HP as first-line treatment of locally advanced/metastatic HER2+ breast cancer
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X: "Trastuzumab-Pertuzumab Plus…
Dec 13, 2024, 05:49 | Insight
Highlights from Day 3 of SABCS 2024
The SABCS 2024 (San Antonio Breast Cancer Symposium) is taking place from December 10th to…
Aug 6, 2024, 02:02 | Insight
Trastuzumab deruxtecan therapy in patients with HER2-positive metastatic breast cancer
Francisco Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared…
All: 7 Posts: 1 - 100
Special Coverage